Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA considers adding a dozen peptides to its bulk drug compounding list RAPS